Novocure (NVCR) Tops Q2 EPS by 2c

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.36), $0.02 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $158.8 million versus the consensus estimate of $153.33 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue
• JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue